India to United States: Itraconazole Export Trade Route
India has recorded 125 verified shipments of Itraconazole exported to United States, representing a combined trade value of $6.3M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $50.0K USD. The leading Indian exporter is ANNORA PHARMA PRIVATE LIMITED, which accounts for 35% of total export value with 14 shipments worth $2.2M USD. On the buying side, AMNEAL PHARMACEUTICALS, LLC (KY) is the largest importer in United States with $957.8K USD in purchases. The top 3 suppliers — ANNORA PHARMA PRIVATE LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, ALKEM LABORATORIES LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Itraconazole corridor is one of India's established pharmaceutical export routes, with 125 shipments documented worth a combined $6.3M USD. The route is dominated by ANNORA PHARMA PRIVATE LIMITED, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's itraconazole manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $50.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with itraconazole's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 25.7%, placing it at rank #10 among India's top itraconazole export destinations globally.
On the import side, key buyers of Indian itraconazole in United States include AMNEAL PHARMACEUTICALS, LLC (KY), ASCEND LABORATORIES,LLC, TO THE ORDER OF.... and 29 others. AMNEAL PHARMACEUTICALS, LLC (KY) is the single largest importer with 12 shipments valued at $957.8K USD.
